Slingshot members are tracking this event:

Endo Announces FDA Advisory Committee Meeting For OPANA ER; date of July 29, 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
ENDP Community voting in process

Additional Information

Additional Relevant Details As a result of the Advisory Committee meeting, the current Prescription Drug User Fee Act (PDUFA) date of July 29, 2016 for the OPANA® ER sNDA will not be met and the action on the supplement is expected to be taken by the FDA as soon as possible following the Advisory Committee meeting.
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 12, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Opana Er, Advisory Committee Meeting